Gene signal GS-101 data shows safe and effective inhibition of ophthalmic blood vessel growth
Tuesday, September 1, 2009 - 04:42
in Health & Medicine
Lausanne, Switzerland -- Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).